Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sperginn Forte is a multi-ingredient dietary supplement developed by INNventa Pharm, specifically formulated to support male reproductive health and address male infertility. It is primarily indicated for improving sperm parameters, including count, motility, and morphology, in conditions such as oligoasthenoteratozoospermia (OAT). The formulation contains a high concentration of L-arginine, which serves as a precursor for nitric oxide to improve blood flow to the reproductive organs, alongside L-carnitine and L-taurine for sperm energy metabolism. Additionally, it includes a complex of antioxidants and essential minerals—Coenzyme Q10, Vitamin E, Zinc, and Selenium—which work synergistically to protect sperm DNA from oxidative stress and support healthy spermatogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sperginn Forte.